Skip Ribbon Commands
Skip to main content
Translate
Translate
menu iconMenu
search iconSearch

UC San Diego Health Sciences Announces Collaboration With Johnson & Johnson Pharmaceutical Research & Development

 

November 20, 2008  |   

University of California, San Diego Health Sciences leaders have announced that they have executed a formal Memorandum of Understanding (MOU) with Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (J&JPRD), with the objective of developing future collaborations in biomedical research and education to advance human health.

The MOU establishes a framework for future research and training efforts between the UC San Diego School of Medicine, Skaggs School of Pharmacy and Pharmaceutical Sciences and the UC San Diego Medical Center health system, and J&JPRD, a pharmaceutical research and development company with expertise in small molecules, genomics, bioinformatics, high throughput screening, and structural biology.

“We are excited about this tremendous opportunity to partner with J&JPRD, which is a world leader in the development of new drugs.  This collaboration will further accelerate our efforts at UC San Diego to translate the exciting discoveries being made every day in our laboratories into improved diagnostic and treatment technologies that benefit all patients,” said David Brenner, M.D., UC San Diego Vice Chancellor for Health Sciences.  “The ability to work more closely with colleagues in the private sector will strengthen our translational research program, and enhance the education of our medical, pharmacy and graduate students, in addition to boosting the potential for new product development.”

Brenner joined with G. Diego Miralles, M.D., Head and Chief Medical Officer of J&JPRD’s Research and Early Development unit based in San Diego, to sign the MOU in ceremonies at the UC San Diego School of Medicine.

J&JPRD MOU signing

L to R: G. Diego Miralles, M.D., David Brenner, M.D., and Larry Brunton, Ph.D.

Echoing Dr. Brenner’s enthusiasm, Dr. Miralles noted that "academia and industry are natural partners since we have complimentary expertise and share the common goal of addressing unmet medical needs. Working closely with our neighbors at UCSD will help us find win-win opportunities and maximize our common capabilities.  We are very excited about the potential of this partnership.”

The two organizations plan to create education, training and research collaborations in biomedical science, medicine and public health, with a focus on projects that lead to new clinical applications.  In addition to signing the MOU, the organizations also signed the first agreement between UC San Diego Health Sciences and J&JPRD under the MOU framework – a contract for UC San Diego Professor of Pharmacology Larry Brunton, Ph.D., to conduct laboratory studies to evaluate the effects of new compounds on heart tissue. 

UC San Diego School of Medicine is one of the nation’s top biomedical research medical schools, ranked 14th in the nation by U.S. News and World Report among research medical schools.  The new UC San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences is dedicated to training the pharmacists of the future and to research focusing on drug discovery.  UC San Diego has an established history of partnering with industry in order to facilitate the development of drugs and technologies based on research discoveries, and is credited with helping to lay the foundation for San Diego’s emergence as a global biotechnology and pharmaceutical hub.

# # #

Media Contact: Leslie Franz, 619-543-6163, lfranz@ucsd.edu



Media Contact

Related News

4/22/2015
UC San Diego Health System and Scripps Health are partnering to provide improved continuity of patient care, fellowship training and research in hospice and palliative medicine. Under a new five-year ...
4/20/2015
Researchers at the University of California, San Diego School of Medicine and Moores Cancer Center have discovered a molecular mechanism that connects breast tissue stiffness to tumor metastasis and p ...
4/20/2015
A decrease in the amount of time spent eating and an increase in overnight fasting reduces glucose levels and may reduce the risk of breast cancer among women, report University of California, San Die ...
4/20/2015
The threat of falsified medications, also referred to as counterfeit, fraudulent, and substandard, can be quite real, yet the full scope and prevalence of the problem is poorly understood, say researc ...
4/17/2015
Researchers at the University of California, San Diego School of Medicine have created an in vitro, live-cell artificial vessel that can be used to study both the application and effects of devices us ...
4/16/2015
The increase in use of e-cigarettes has led to heated debates between opponents who question the safety of these devices and proponents who claim the battery-operated products are a useful cessation t ...
4/16/2015
An international team of scientists, led by researchers at University of California, San Diego School of Medicine, have found genetic overlap between Alzheimer’s disease (AD) and two significant cardi ...
4/13/2015
About one quarter of all atrial fibrillation patients at the lowest risk for stroke receive unnecessary blood thinners from cardiology specialists, according to a new study by researchers at Universit ...